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Tissues and organs can be damaged by, or become
dysfunctional through, inflammation, trauma, and degen-
eration. Traditional therapies for restoring diseased tissues
and organs using autografting or allografting are not always
satisfactory. Autografting is performed at the expense of
using healthy tissue from elsewhere in the body, and
therefore, the source of donor organs is limited and com-
plications and additional damage can occur. Medication andf Orthopedics, Chinese PLA
dian District, Beijing 100853,
.com (J. Peng).
02.003
hors. Published by Elsevier (Singap
licenses/by-nc-nd/4.0/).temporary replacement therapy can resolve the organ
dysfunction, but is not available to every patient.
In the 1980s, researchers proposed the concept of tissue
engineering, which revolutionized the treatment of tissue
defects and organ failure [1]. The most-studied problems in
tissue engineering include how to obtain sufficient numbers
of cells with the original phenotype, how to prepare the
best scaffold, and how to load factors into a scaffold to
achieve the long-term controlled release of factors; these
can be considered the seeds, soil, and fertilizer, respec-
tively. Cells cultured in vitro in conventional monolayers
can lose their characteristic morphology, and the cell-
specific extracellular matrix (ECM) secretion can be
altered. For example, chondrocytes can develop into
spindle-shaped fibroblast-like cells that secrete fibrous
tissue or fibrocartilage [2,3]. Traditional two-dimensionalore) Pte Ltd. This is an open access article under the CC BY-NC-ND
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passaging [4]. High cell-density cultures favour the main-
tenance of the cell phenotype and prevent dedifferentia-
tion. Cells under three-dimensional (3D) culture are
stimulated mechanically, enabling them to retain a stable
phenotype [5]. Because most seed cells are adherent, good
adhesion on the microcarrier for growth and maintenance
of differentiation and function in vitro for constructing
tissue-engineered tissues is the key technology, especially
for large-scale engineering of skin, bone, cartilage, and
tendons, [6,7,8,9]. The traditional static culture method
has many disadvantages, such as a small specific surface,
the inhomogeneous diffusion of nutrients and metabolites,
and slow cell growth affecting the final production [5].
In 1967, van Wezel [10] used the first microcarrier,
diethylaminoethyleSephadex A50. Subsequently, it has
played an important role in the proliferation of anchorage-
dependent cells in the large-scale cultivation of animal
cells. The technology developed rapidly in the 1980s and
achieved marked success. Since then, the commercializa-
tion of microcarriers has increased and commercial micro-
carriers include Hillex, Glass Coated, Plastic Plus Coated,
Rapid Cell P, Cytodex-3, Cytodex-2, and Cytodex-1. The
material nature, surface properties, and microcarrier par-
ticle size are important factors affecting cell adhesion and
proliferation. To improve the performance of the micro-
carrier in order to obtain better adhesion and proliferation,
the microspheres are specially treated. The greatest
benefit of microcarrier culture is that the microtissues
formed by cells and microcarriers can be delivered to the
sites of defects, thereby eliminating the digestion of cells
before transfer in monolayer culture from flasks [11].
Here, we give an overview of microcarrier culture
technology, its importance as an ex vivo research tool, and
its potential application in vivo. Microcarriers are a prom-
ising culture system for producing great quantities of cells
and microtissue for tissue engineering.Microcarrier materials
Depending on the source, the materials used as micro-
carriers can be divided into two categories, namely, syn-
thetic and natural polymers. Early microcarriers were
mostly constructed from synthetic polymers, such as poly-
hydroxyethylmethacrylate, polystyrene, polyacrylamide,
polyurethane foam, and glucose. Although microcarriers
made from synthetic polymers showed good reproducibility
and mechanical properties, they lacked cell recognition
sites and affected cell adhesion and growth [12]. There-
fore, researchers are now using natural polymers and their
derivatives as the material of choice because they are
easily obtained, biocompatible, and inexpensive [9,13].
Here, we review various natural polymers that were used to
prepare microcarriers.
Gelatin is produced from collagen by mild, irreversible
degradation. It has good biocompatibility and is relatively
inexpensive. The presence of keratin, elastin protein
gelatin, melanocytes, and chondroitin are important in
promoting cell growth and adhesion [14]. Microcarriers
made of many other substrates, such as Cytodex-3 and CT-
3, are often encapsulated with a layer of gelatin to improvetheir biocompatibility. Commercial gelatin microcarriers
include GELIBEAD (Hazelton Research Products, Reston,
Virginia, USA), Ventregel (Ventrex Laboratories, Portland,
Maine, USA), and CultiSpher (HyClone, Loagen, Utah, USA).
Collagen is a biological material that can be used for
guided tissue regeneration, as it is nonantigenic, has good
biocompatibility, and works in the tissue-healing process.
Some specific sites of the polypeptide in the primary
structure of denatured collagen combine with fibres in the
culture medium to form a collagenefibre complex that
contributes to cell adhesion and growth [15]. Widely used in
animal cell cultures, Cytodex-3 (Pharmacia) and the porous
Microsphere (Verax) use collagen as a substrate. Collagen
has been used to coat the surfaces of microcarriers; Hong
et al. [16] produced an injectable scaffold for cartilage
regeneration using a collagen-coated polylactide micro-
carrier/chitosan hydrogel composite. The cell metabolic
activity increased rapidly with the chondrocyte/composite
scaffold.
Cellulose is a homopolymer of D-glucose connected by b-
1,4-glycosidic bonds. Cytopore is a commercial fibrin
microcarrier [17] that has high mechanical strength and can
be recycled.
The biocompatible chitin and its derivative chitosan
promote wound healing, are antibacterial, and have other
biological functions. Chitosan is the product of chitin
deacetylation and its molecular chains are linked by
hydrogen bonds. The glycosidic bonds confer rigidity and
stability to the molecule; the hydrogen bonds are electro-
positive; the acetyl groups are hydrophobic; and the hy-
droxyl groups are hydrophilic, although chitosan is not
soluble in water. Chitin and its derivatives are biological
materials and they can also be used as cell culture scaffolds
in tissue engineering [18,19].
Alginic acid is widely used as a fixing material for the
drug-controlled release of proteins, cells, and DNA. It can
be absorbed with no adverse reactions. Cartilage cells
cultured in an alginate carrier can synthesize an ECM
similar to that of natural cartilage [20].
The ECM consists mainly of polysaccharide, protein, and
proteoglycan macromolecules that are synthesized and
secreted by animal cells. These compounds are located on
the cell surfaces or between the cells [21]. They form a
complex network and support and connect the organiza-
tional structure, and regulate tissue and cell physiological
activities. The ECM is part of the animal tissue and does not
belong to any cell. It determines the characteristics of the
connective tissue and plays an important role in some an-
imal cells. Even in vitro, ECM plays a crucial role in the cell
culture process. It provides a similar microenvironment to
that in vivo, which is better for the growth of cells. Many
tissue-engineering studies have investigated ECM [9,22].Classification of microcarriers
Based on their physical characteristics, microcarriers can
be divided into two main categories, namely, solid and
liquid microcarriers.
Solid microcarriers have advantages in terms of the
adherence and expansion of cells (Table 1). The Cytodex
series is widely used. Solid microcarriers are prepared by
Table 1 Commercial microcarriers and their physicochemical parameters.
Name Size (mm) Density
(g/mL)
Material Refs
Cytodex-1 60e87 1.03 Dextran matrix with positively charged diethylaminoethyl
groups throughout the matrix
[25,38]
Cytodex-2 60e87 1.04 Dextran matrix with N,N,N-trimethyl-2-hydroxyaminopropyl groups [25]
Cytodex-3 60e87 1.04 Dextran beads coated with denatured porcine-skin collagen
bound to surface
[16,39]
Cytopore 1 200e280 1.03 Cellulose [17,27]
CultiSpher G 130e380 1.04 Cross-linked porcine gelatin [43,48]
CultiSpher S 130e380 1.04 Cross-linked porcine gelatin [62]
Hillex 150e210 1.1 Dextran matrix with treated surface [25]
Glass coated 90e150 1.05 Glass [6]
Microcarrier-based tissue engineering 53suspension polymerization, by which Pis‚kin et al. [23] ob-
tained a polydimethylsiloxane-OH microcarrier, which has a
diameter of approximately 200 mm. Gabler et al. [24] pre-
pared a poly(lactide-co-glycolide) (PLGA) microcarrier by
emulsification, while controlling the polymer concentration
and stirring speed to produce microspheres in the size
range of 40e330 mm. Cartilage cells in the microcarrier
culture had a 100% survival at 3e5 days, but had degraded
by 3 months. Cytodex-1 microcarriers are a suitable sub-
strate for the propagation of articular bovine chondrocytes.
When cultured on a Cytodex-1 microcarrier, chondrocytes
partly revert to their differentiated phenotype [25]. The
surface of the Cytodex-3 microcarrier is covered with a
layer of collagen, which provides a natural microenviron-
ment. The cells can adhere, grow rapidly, and be cultured
for a long time with this microcarrier. Compared with
Cytopore, solid microcarriers have a smaller specific area
and final cell density. Kinetic factors such as fluid-induced
shear stress, collisions, and stirring can damage cells
cultured on solid microcarriers [26]. In the 1980s, this
procedure advanced greatly with the development of a
series of porous microcarriers. Macroporous microcarriers
offer internal spaces where cells can be anchored or
embedded and grow to a high cell density in a pseudosus-
pension culture. The macroporous microcarriers allow for
high cell-to-bead loadings within the matrix of the carriers
and shelter cells from any effects of the shear forces
generated in a bioreactor [27]. Various macroporous
microcarriers have been tested. Cytopore is a charged
cross-linked cellulose microcarrier suitable for stirred-tank
cultures. A major advantage is that the embedded cells are
protected against any shear forces that might be generated
within the bioreactor. However, a potential disadvantage is
possible diffusion limitations for nutrients and oxygen that
might result in necrotic foci deep within the microcarrier
[28]. However, cells growing in 3D cultures also have po-
tential disadvantages: there are limitations to oxygen and
nutrient transport, and the accumulation of waste products
inside the structures can affect cell proliferation and
viability as well as productivity and product quality [29].
Liquid microcarriers provide a special interface for ani-
mal cells. Anchorage-dependent animal cells are cultured
using a solid surface such as polystyrene dishes for micro-
carriers [30] and macroporous carriers [31]. The sub-
cultivation and collection of cells need a proteolytic enzymesuch as trypsin or require mechanically scraping the cells.
However, these measures can have adverse effects, such as
the proteolysis of the cell membrane and degeneration of
cell activities. Cell membrane proteins are degenerated by
trypsin treatment and mechanical scraping [32]. To remove
this obstacle, a cell cultivation method using a liquid/liquid
interface system was proposed [33]; anchorage-dependent
animal cells can adhere, spread, and grow at the interface
between the culture medium and a hydrophobic liquid.
Initially, researchers showed that the cells could grow at the
interface. This culture system developed from a simple hy-
drophobic liquid into using synthetic liquid per-
fluorochemicals. It was believed to be limited to animal cells
and there was no detailed analysis of cell morphology or
characteristics [34]. However, Pilarek et al. [35] studied the
morphological features, growth characteristics, and physi-
ology of mammal cells cultured using liquid microcarriers
and found that the liquid/liquid system is simple and is fully
scalable for the 3D culture of adherent animal cells. The
anchorage-dependent animal cell growth is not limited by
the confluence effect [35]. This culture system is simple and
flexible (independent of vessel shape). In addition, it does
not require the scaffolds or inserts traditionally used for the
3D culture of animal cells. Hence, liquid microcarrier sys-
tems have promise in tissue engineering.Development of microcarriers
Given the limitations of monolayer culture, such as
expansion in a short period and maintenance of cell
morphology, researchers have conducted in-depth studies
to improve the conditions. Freed et al. [36] cultured
chondrocytes in bioreactors and found that such cell cul-
ture was quicker for harvesting double cells than culture on
plastic. However, the adhesion between the microcarrier
and cells was weak, so the cells fell off easily. Improve-
ments in the surface and inside of microcarriers have been
studied, and components of ECM have been added to the
microcarrier material.
When a new microcarrier is being made, its hydrophi-
licity and charge characteristics should be examined care-
fully. Improved methods commonly used are chemical,
plasma, and surface modification. Chemical modification
can change the material composition by co-polymerization,
54 B. Li et al.grafting, and other methods to obtain a better affinity on
the surface. Plasma modification refers to introducing
microcarrier surface functional groups or other specific
polymer chains. Surface modification can enhance cell
adhesion by fixing a number of adherent factors, such as
polylysine and collagen. Tan et al. [37] immobilized the
tetrapeptide RGDS onto PLGA/gelatin microcarriers using
an emulsion-solvent evaporation technique. The RGDS
peptides were further immobilized on the microcarriers
using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. The
PLGA/gelatineRGDS microcarriers seeded with rabbit
chondrocytes in vitro showed the best performance in
terms of chondrocyte attachment, proliferation, viability,
and sulfated glycosaminoglycan secretion compared with
PLGA or PLGA/gelatin alone.
Frondoza et al. [38] cultured chondrocytes from human
knees using collagen type I microcarriers and found that the
cells multiplied at least 20-fold within 14 days, had a
doubling time of 2e3 days, and showed enhanced expression
of cartilage-related genes. Based on the Cytodex-1 micro-
carrier, Cytodex-3 adds a coating of collagen types I and III
from porcine skin to improve adhesion. Hong et al. [39] re-
ported that collagen-coated polylactide microcarriers were
adhesive. The ECM provides connections and interactions for
cells, separates different tissues, controls signal channels,
and can also regulate dynamic behaviours related to cell
survival, expansion, death,morphology, differentiation, and
migration [40,41,42]. Microcarriers have been made from
ECM, including micronized acellular dermal matrix (MADM)
[9] and decellularized adipose tissue (DAT) [22]. The MADM
microcarriers have good biocompatibility and support
human fibroblast expansion as a direct culture substrate or
by culturing cells in conditioned medium prepared from
them. In an animal study, human fibroblasts seeded on MADM
microcarriers spontaneously formed an engineered particu-
late dermal substitute (EPDS) that could form a thick layer of
tissue under subcutaneous muscle tissue at 3 weeks. In full-
thickness cutaneous wounds, the repair of the wound with
EPDS was good. Potentially, MADM can be used not only as a
cell culture substrate to expand fibroblasts but also as a cell
transplantation vehicle for skin regeneration, with several
advantages over the current expansionetransplantation
protocols. Similarly, human adipose-derived stem cells
seeded on DAT microcarriers and cultured in adipogenic
differentiation medium using a low-shear spinner culture
system showed high levels of adipogenic differentiation [22].
The authors found elevated levels of adipogenic markers in
adipose-derived stem cells cultured on DAT microcarriers in
a proliferation medium. The DAT microcarrier provided an
adipo-inductive substrate for human adipose-derived stem
cells. In vivo, preseeding the DAT microcarriers with allo-
genic rat adipose stem cells enhanced cellularity and
angiogenesis within the implant region. These studies indi-
cate the potential usefulness of a purely natural-material
microcarrier in other tissue-engineering fields. ECM-
derived microcarriers have the unique advantage of pro-
moting cell proliferation and formation of microtissue. They
can provide a similar in vivo microenvironment and growth
factors in in vitro culture, which ensures the quality and
quantity of tissue-engineering seed cells. Hence, in other
fields of tissue engineering, tissue-derived ECM can be used
as a microcarrier.Microcarriers as cell-delivery systems
At the initial stage of microcarrier development, micro-
carriers could amplify cells and effectively maintain cell-
specific phenotypes [43]. With gradual improvement in
microcarrier culture technology and the application of
biodegradable materials, microcarriers with tissue-
engineered scaffolds have helped in the repair of damaged
or degenerated tissue and the restoration of the original
tissue structure and function. For example, microcarrier-
attached hepatocytes were transplanted intraperitoneally
into rats with GalN-induced acute liver failure. They pro-
vided sufficient metabolic support, represented by the
detoxification of ammonia (and presumably bilirubin) and
synthesis of albumin, to enable the restoration of liver
function [44]. Adipose-derived mesenchymal stem cells
cultured on MADM, micronized small intestinal submucosa,
and gelatinmicrocarriers as expansion and delivery scaffolds
implanted on mouse full-thickness cutaneous wounds
resulted in good skin regeneration and subcutaneous soft-
tissue augmentation [13]. To heal full-thickness wounds,
epidermal keratinocytes, epidermal cells, and fibroblasts
have also been used [9,45,46]. Collagenealginate micro-
carriers embedded with a large number of human adipose-
derived stem cells were injected subcutaneously into the
heads of nudemice, which formed adipose tissue, with blood
vessel ingrowth and anastomosis [47]. In the early years,
human keratinocyte microcarriers were used to heal recal-
citrant venous leg ulcers, reducing the initial wound area in a
clinical study [48]. Hartmann et al. [49] found that the
transplantation of autologous keratinocytes suspended in
fibrin was effective for treating chronic venous leg ulcers,
although the fibrin carrier used at present must be removed
after a few days because of antimigratory and survival-
compromising effects. The intrastriatal implantation of
human retinal pigment epithelial cells improved motor
symptoms in an exploratory, open-label, single-centre study
of unilateral transplantation in six patients with advanced
Parkinson disease [50,51,52,53]. However, human retinal
pigment epithelial cells cultured on steam-sterilized 100-mm
cross-linked porcine gelatin microcarriers and transplanted
into the striatum provided no anti-Parkinsonian benefits
compared with sham surgery [54]. Whether the results were
due to a large, persistent placebo response is unknown.
Calcium titanium phosphate microcarriers were used to
culture osteoblasts and these promoted cell proliferation
and ECM secretion [55,56]. These materials were used to
repair bone defects due to osteoconduction and promoted
cell function and bone bonding. Unfortunately, the beads
collided with the bioreactor walls in the 3D suspension cul-
ture because of the relatively high density of these mate-
rials. Consequently, the microcarriers were used only in
plastic culture. A good start was obtained with a shell-
structured cell microcarrier, which solved the problem of
collision and promoted osteoblast proliferation and bone
microstructure formation [57,58]. In cartilage tissue engi-
neering, autologous chondrocytes from mini pigs were
seeded on hydrogel-coated microcarriers to form micro-
tissue that was used to repair full-thickness cartilage de-
fects, demonstrating nearly complete cartilage
regeneration in microtissue-treated defects [59].
Microcarrier-based tissue engineering 55Microcarrier technology has improved gradually over 40
years of development and is now maturing. In tissue engi-
neering, this technology has been used successfully as cell-
delivery systems for hepatocytes, fibroblasts, chon-
drocytes, and with other cells for large-scale cultivation
and the repair of tissue defects. Because the structures of
the skin and adipose tissue are relatively simple, engi-
neering of these tissues is relatively easy. However, can we
achieve success in regenerative medicine using micro-
tissues for complex tissues and organs? For example, the
structure of the liver is very complex, with lymph vessels,
arteries, veins, bile vessels, and liver parenchyma. Micro-
tissues composed of human artery-derived fibroblasts and
endothelial cells were cultured in a novel bioreactor
designed to assemble the microtissues in a vascular shape.
A layered tissue formed, which might be used to generate
small-diameter tissue-engineered living blood vessels
[60,61]. If we first seed the same cells on a microcarrier
made from decellular vessel tissue and then culture the
complex in a custom bioreactor, we might obtain tissue-
engineered living blood vessels of different diameters or
even tissue-engineered bile vessels (Fig. 1). For the liver
parenchyma, we could first create a custom bioreactor
using 3D printing technology, then create a decellular liver-Figure 1 A schematic image of a custom bioreactor setup. The se
device, and the medium reservoir. Amplification of assembly devic
assemble the microtissue consists of a cell filter membrane (to av
wallboard. The thickness between the edge of the column and the
thickness of the vessel wall.parenchyma-derived microcarrier, and finally seed hepa-
tocytes to construct a microtissue for culture in the custom
bioreactor. Ultimately, the liver parenchyma would be in-
tegrated with the vasculature by surgery.Conclusion and future directions
Microcarrier technology has advantages for producing great
numbers of functional cells and maintaining their special
phenotypes, as a powerful source of cell therapy, and for
tissue engineering. With the improvements in microcarrier
materials, especially purely natural-material microcarriers,
tissue engineering has a bright future. Several purely
natural-material microcarriers, such as MADM and DAT
microcarriers, have already shown impressive clinical
application. They have good biocompatibility and can pro-
vide appropriate microenvironments during culture in vitro
where cells are easy to proliferate; they maintain the cell
phenotype and, more importantly, can form microtissue,
which can be transplanted into defects and degenerate sites
to restore the integrity of structure and intrinsic function.
Significant progress has been made since the first
microcarrier was invented by van Wezel [10] in 1967.tup is composed of three components: the pump, the assembly
e shows the internal fluid flow routes. The custom module to
oid cell loss), the outer silicon column, and the nonadhesive
inner nonadhesive wallboard is 1e2 mm, which determines the
56 B. Li et al.Microcarriers have achieved wide application as prolifera-
tion carriers and cell-delivery systems. The materials of
microcarriers are improving from artificial to purely natural
materials, thus constituting promising research tools in
tissue engineering. A microtissue is first constructed using a
purely natural microcarrier (decellular tissue-derived ma-
trix), and then transplanted into a custom bioreactor to
form a tissue or organ. These microtissues will become the
basis of regenerative medicine.
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